Form 4 for EW Edwards Lifesciences
Accepted 2025-08-25 00:00:00 ET · period of report 2025-08-25 · accession 0001225208-25-007460 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-25 | 2025-08-25 | EW | Chopra Daveen | CVP, TMTT | S - Sale | $81.95 | -2,500 | 31.0K | -7% | -$204.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-25 | S | D | 2,500 | $81.95 | 30,996 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $81.9401 to $81.9500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |